Human Papilloma Virus 16 Capsid Protein (HPV-16 L1) anticorps

N° du produit ABIN5707603

Cet anticorps anti-Human Papilloma Virus 16 Capsid Protein Monoclonal Souris (Clone rHPV16L1-1058) (ABIN5707603) détecte spécifiquement Human Papilloma Virus 16 Capsid Protein dans IHC (p). L’anticorps est réactif avec des échantillons de Human Papillomavirus 16 (HPV-16).

Aperçu rapide pour Human Papilloma Virus 16 Capsid Protein (HPV-16 L1) anticorps (ABIN5707603)

Antigène: Human Papilloma Virus 16 Capsid Protein (HPV-16 L1)

Reactivité: Human Papillomavirus 16 (HPV-16)

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: RHPV16L1-1058

Détail du produit

Purification: Purified

Pureté: Protein G affinity chromatography

Immunogène: Human papilloma virus type 16, major capsid protein L1, was used as the immunogen for the recombinant HPV16 L1 antibody.

Isotype: IgG1 kappa

Information d'application

Indications d'application: Optimal dilution of the recombinant HPV16 L1 antibody should be determined by the researcher.

1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT,Prediluted IHC only format : incubate for 30 min at RT (1)

Restrictions: For Research Use only

Stockage

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the recombinant HPV16 L1 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détail du antigène

Antigène: Human Papilloma Virus 16 Capsid Protein (HPV-16 L1)

Autre désignation: HPV-16 L1

Classe de substances: Viral Protein

Sujet: Reacts with a protein of 57  kDa, identified as the L1 protein of human papilloma virus type 16 (HPV-16). It is the major capsid protein of HPV-16. Infection with specific types of HPV has been associated with an increased risk of developing cervical neoplasia. HPV types 6 and 11 have been associated with relatively benign diseases such as genital warts but types 16 and 18 are strongly associated with cervical, vaginal, and vulvar malignancies. The antibody reacts very strongly with formalin-fixed, paraffin-embedded tissues containing HPV-16 or -33, very weak reactions were occasionally observed with biopsy specimens or smears containing HPV-6 or HPV-11. It cross-reacts with HPV37.